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Biliary strictures are one of the most common complications 
following liver transplantation, representing an important 
cause of morbidity and mortality in transplant recipients. The 
reported incidence of biliary stricture is 5% to 15% following 
deceased donor liver transplantations and 28% to 32% fol-
lowing living donor liver transplantations. Bile duct strictures 
following liver transplantation are easily and conveniently 
classiﬁ  ed as anastomotic strictures (AS) or non-anastomotic 
strictures (NAS). NAS are characterized by a far less favorable 
response to endoscopic management, higher recurrence 
rates, graft loss and the need for retransplantation. Current 
endoscopic strategies to correct biliary strictures following 
liver transplantation include repeated balloon dilatations and 
the placement of multiple side-by-side plastic stents. Endo-
scopic balloon dilatation with stent placement is successful 
in the majority of AS patients. In patients for whom gaining 
biliary access is technically difﬁ  cult, a combined endoscopic 
and percutaneous/surgical approach proves quite useful. 
Future directions, including novel endoscopic retrograde 
cholangiopancreatography techniques, advanced endoscopy, 
and improved stents could allow for a decreased number of 
interventions, increased intervals before retreatment, and 
decreased reliance on percutaneous and surgical modali-
ties. The aim of this review is to detail the present status of 
endoscopy in the diagnosis, treatment, outcome, and future 
directions of biliary strictures related to orthotopic liver trans-
plantation from the viewpoint of a clinical gastroenterolo-
gists. (Gut Liver 2011;5:133-142)
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INTRODUCTION
Liver transplantation is a life saving procedure for patients 
with chronic end-stage liver disease and acute liver failure when 
there are no available medical and surgical treatment.
1-3 Since 
Thomas Starzl performed the first liver transplantation in 1963, 
there have been significant advances in all aspects of organ 
selection, retrieval, preservation, and implantation techniques. 
Therefore, the overall 1-year survival for adult and pediatric 
deceased donor liver transplantation (DDLT) is now expected to 
be in excess of 85%, with 5- and 10-year survival in excess of 
70% and 60%, respectively.
4-7 However, complications of the 
biliary tract remains a common source of morbidity and mortal-
ity. Some authors call it “Achilles heel of orthotopic liver trans-
plantation.”
8
Biliary leaks and strictures are the most common biliary com-
plications, but sphincter of Oddi dysfunction, hemobilia, and 
biliary obstruction from cystic duct mucocele, stones, sludges or 
casts have also been observed.
9-11 The rate of bile leaks or stric-
tures at the anastomotic site or cut edge of the transected liver, 
were reported in 15% to 60% of recipients in early, single center 
reports.
12 These high rates of post-transplant biliary complica-
tions, may point to an inherently sensitive nature of the biliary 
epithelium to ischemic damage in comparison to hepatocytes 
and vascular endothelium.
13 
Improving survival of liver transplants, biliary complications 
also increased in long-term survival patients. These complica-
tions not only affect graft survival but also have a major impact 
on the quality of life for a liver allograft recipient, as they lead 
to frequent readmission, reoperation, hospital stays, and escalate 
costs and add to the emotional trauma that patients suffer. 
Surgical repair traditionally has been the preferred approach 
in biliary complication of orthotopic liver transplantation. With 
advances in therapeutic and diagnostic endoscopy, the non-
operative management of biliary complications has become 
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standard techniques as the preferred diagnostic and therapeutic 
modalities.
The aim of this review is to overview a present status of en-
doscopic role in the diagnosis, treatment, outcome, and future 
directions of biliary stricture related to orthotopic liver trans-
plantation, from the viewpoints on clinical gastroenterologist.  
INCIDENCE OF BILIARY STRICTURES
Studies regarding long-term outcomes after liver transplanta-
tion indicate that approximately 5% to 30% of recipients will 
develop biliary complications after transplantation. The most 
common biliary complications are bile leaks, anastomotic and 
intrahepatic strictures, stones, and ampullary dysfunction. Leaks 
predominate in the early posttransplant period (<3 months). 
Stricture formation typically develops gradually over time. 
Biliary strictures are the most frequent type of late biliary com-
plication (>3 months) and are typically due to ischemia/reperfu-
sion injury, vascular insufficiency, or fibrotic healing caused by 
improper technique.
14-17
Although the strictures can present at any time after the 
surgery, the mean interval at the time of presentation is 5 to 8 
months after orthotopic liver transplantation and the majority 
present within 1 year,
17-22 but recent studies suggest that their 
prevalence continue to increase with the time after transplanta-
tion.
23
CLASSIFICATION OF BILIARY STRICTURES
Bile duct strictures after liver transplantation are easily and 
conveniently classified as anastomotic strictures (AS) and non-
anastomotic strictures (NAS). The clinical outcomes of the 2 
types are markedly different, rendering their distinction clini-
cally relevant. 
NAS account for 10% to 25% of all stricture complications 
after orthotopic liver transplantation, with an incidence of 1% 
to 19%; these are often multiple, longer and occur earlier than 
anastomotic strictures. AS, on the other hand, are isolated, are 
localized to the site of the anastomosis, and are short in length. 
Their reported incidence in the modern literature is 4% to 9%.
PATHOGENESIS AND RISK FACTORS
1. AS
The underlying basis for AS includes ischemia or fibrosis 
following a suboptimal surgical technique or a bile leak in the 
postoperative period.
21,23,24 Early in the postoperative period, 
technical issues appear to be the most important: improper 
surgical techniques, small caliber of the bile ducts, a mismatch 
in size between the donor and recipient bile ducts, inappropri-
ate suture material, tension at the anastomosis, excessive use of 
electrocauterization for control of bile duct bleeding, and infec-
tion.
8 
Later onset anastomotic strictures most likely indicate fibrotic 
healing arising from ischemia at the end of the donor or recipi-
ent bile duct.
14-16,21,23-25
According to some series of whole organ orthotopic liver 
transplantation, they are reported to be more common after 
hepaticojejunostomy than after direct duct-to-duct anastomo-
sis,
9,11,26 as well as following duct-to-duct anastomosis in non-
T-tube recipients, as compared to the anastomosis over a T-
tube.
27-30 In right lobe living-donor transplants, the incidence of 
duct to duct anastomotic strictures has been consistently higher, 
as compared to recipients of whole liver grafts.
31-35 This is con-
sidered to be related to the blood supply of the anastomosis and 
often the presence of multiple and small caliber donor ducts.  
2. NAS
NAS are heterogeneous entities, and on the basis of the etiol-
ogy, Moench et al.
36 proposed a classification dividing them 
into NAS secondary to macroangiopathy and NAS secondary to 
microangiopathy (preservation injury, prolonged cold and warm 
ischemia times, donation after cardiac death, and prolonged 
use of vasopressors in the donor) and immunogenicity (chronic 
rejection, ABO incompatibility, autoimmune hepatitis, and pri-
mary sclerosing cholangitis). Less important and inconsistent 
are the reported associations with hepatitis C and cytomegalovi-
rus.
11,37,38
NAS present earlier than AS, with the mean time to stricture 
development being 3.3 to 5.9 months.
20,37 Verdonk et al.
39 fur-
ther reported that NAS secondary to ischemic causes presented 
within 1 year of the transplant, whereas the occurrence after 1 
year was more often related to immunological causes as the risk 
factors. 
PRESENTATION
Patients may be asymptomatic at presentation, with eleva-
tions of serum aminotransferases, bilirubin, alkaline phospha-
tase and/or gamma-glutamyl transferase levels. A high index 
of suspicion must be maintained, as pain may be absent in the 
transplant setting because of immunosuppression and hepatic 
denervation.
40-42
A recent report of 15 patients highlighted the use of serum 
bilirubin >1.5 mg/dL as a better indirect marker of biliary stasis 
in living donor liver transplantation (LDLT) than alkaline phos-
phatase, which is overly sensitive.
43
DIAGNOSIS
Initial evaluation should include liver ultrasound (US) with 
Doppler evaluation of the hepatic vessels. If hepatic artery 
stenosis or occlusion is suspected on Doppler US, hepatic angi-
ography is usually indicated. Unfortunately, in liver transplant Ryu CH, et al: Biliary Strictures after Liver Transplantation  135
patients, abdominal US may not be sufficiently sensitive (sensi-
tivity of 38% to 66%) to detect biliary obstruction.
44
In addition, the size of the duct has not been found to be 
a reliable indicator in following up these patients or in ac-
cessing the response to the treatment. Furthermore, there is a 
significant lack of correlation between the ducal dilatation on 
the ultrasound and the cholangiographic and clinical feature. 
It is not clear why the donor bile ducts do not respond to distal 
obstruction by displaying the same degree of proportional dila-
tion as non transplanted livers.
43 However, It is possible that the 
presence of variable degrees of fibrosis subsequent to the injury 
sustained at the time of the perioperative period results in less 
pliable ducts.
45
Scintigraphy of the hepatobiliary tract with 99-technetium la-
beled iminodiacetic acid identifies strictures with 75% sensitiv-
ity and 100% specificity but a lack of therapeutic benefit limits 
its clinical use.
46,47 
Magnetic resonance cholangiopancreatography (MRCP), 
which has a sensitivity and specificity close to 90% in estab-
lishing the diagnosis of biliary strictures.
48-50 MRCP is currently 
considered an optimal noninvasive diagnostic tool for the as-
sessment of biliary complications after orthotopic liver trans-
plantation.
8 Once MRCP expertise becomes more widely avail-
able, it should have an even more prominent role in limiting the 
role of invasive cholangiography for therapeutic purposes. The 
chief disadvantage is the lack of its therapeutic ability. It can be 
used as the second step after ultrasound in patients for whom 
the use of diagnostic endoscopic retrograde cholangiopancrea-
tography (ERCP) or percutaneous transhepatic cholangiography 
(PTC) carries a higher operational risk. Cholangiography is con-
sidered by all to be the gold standard not only in establishing 
the diagnosis but also in allowing therapeutic intervention in 
the same setting.
51,52 ERCP has the advantage over PTC and is 
the first modality of choice as it is not only more physiological 
but also less invasive. PTC is most often reserved for patients in 
whom ERCP is unsuccessful and in patients with Roux-en-Y he-
paticojejunostomy or choledochojejunostomy. However, newer 
approaches using the variable stiffness colonoscope, double bal-
loon enteroscope, single balloon enteroscope, and spiral overtube 
have been made it possible to reach this difficult area.
19,53-56 The 
characteristic ERCP findings in NAS consist of mucosal ab-
normalities, narrowing, and prestenotic dilatation, whereas the 
findings in AS include a thin, short, localized, isolated narrow-
ing in the area of the biliary anastomosis (Fig. 1).
MANAGEMENT
Historically, the management of post-orthotopic liver trans-
plantation biliary strictures consisted of surgical reconstruction 
in the form of Roux-en-Y hepaticojejunostomy. However, the 
past 2 decades have seen tremendous growth in the evolution of 
endoscopic techniques that they are now considered the treat-
ment of choice for biliary strictures.
57-60
Percutaneous therapy, although it has a success rate of 40% 
to 85% is still considered a second-line option because of the 
invasive nature of procedure and the associated complications 
of hemorrhage, bile leaks and significant morbidity.
61 Surgical 
revision is now reserved for patients who have failed the pre-
ceding measures, and retransplantation is the final option when 
all else fails.
1. NAS
Management of patients with NAS is difficult, and any gener-
alized treatment recommendations are difficult to make. Accu-
mulation of biliary sludge and casts renders therapy particularly 
difficult because of rapid stent occlusion. Treatment of NAS 
did not result in significant long-term improvement of liver 
chemistries. It does not appear that the poor response of non-
anastomotic treatment to treatment varies with etiology.
37 Most 
importantly, NAS resulted in significantly increased graft loss. 
Fig. 1. Cholangiogram of an anas-
tomotic stricture and a non-anasto-
motic stricture. (A) Short localized 
anastomotic stricture (arrow). (B) A 
long nonanastomotic stricture ex-
tending proximally from the anasto-
mosis site.136  Gut and Liver, Vol. 5, No. 2, June 2011
NAS are more resistant to endoscopic treatment, the results 
of endoscopic approaches have been particularly disappointing 
in the context of NAS in LDLT. The average success rate varies 
from 25% to 33%,
32,62,63 which is way below the 60% success 
rate seen with NAS in DDLT. 
Endoscopic therapy of non-anastomotic strictures typically 
consists of extraction of the biliary sludge and casts and bal-
loon dilation of all accessible strictures followed by placement 
of plastic stents with replacement every 3 month.
37 However, 
balloon dilation of all stricture is not feasible and rapid stent 
clogging is frequently occurred when managing NAS. There-
fore, patients with NAS may required early retransplantation, 
endoscopic therapy appears to play a more prominent role as a 
bridge to liver retransplantation.
14,64
2. AS
The conventional method of endoscopic treatment consists of 
identification of the opening of the stricture followed by cannu-
lation by the guidewire, balloon dilatation of the stricture, and 
subsequent placement of plastic stents. 
Balloon dilation alone without stent placement is only suc-
cessful in approximately 40% of cases.
60 However, Balloon 
dilation with additional stent placement appears to be more 
successful with a durable outcome in 75% of patients with 
anastomotic strictures.
60,65 The stents are generally replaced 
by larger stents every 3 month to prevent the complication of 
clogging, cholangitis, or stone formation.
59,60,66 Dual or multiple 
stents, by providing greater dilatation, have shown better results 
than single stents.
20,60 Placement of not one, but multiple side-
by-side plastic stents further increases successful outcomes in 
80% to 90% of patients.
59,67,68 In some patients, a transient nar-
rowing at a duct to duct connection appear within the first 30 to 
60 days after transplantation, due to postoperative edema and 
inflammation. This type of stricture responds well to balloon 
Fig. 2. A case of anastomotic stricture in a living donor liver transplantation. (A) Retrograde cholangiogram showing a biliary stricture at the 
anastomotic site (arrow). (B) Insertion of two straight plastic stents across the anterior duct. (C) Six-month follow-up cholangiogram showing 
resolution of the stricture.
Fig. 3. Case of anastomotic stricture in a deceased donor liver transplantation (DDLT). (A) A biliary stricture is shown in the anastomosis site fol-
lowing the DDLT (arrow). (B) Two straight plastic stents were inserted through an anastomosis stricture. (C) The biliary stricture was resolved after 
3 months.Ryu CH, et al: Biliary Strictures after Liver Transplantation  137
dilatation and temporary stent placement.
42 Most patients with 
anastomotic strictures require ongoing ERCP sessions every 3 
month with balloon dilation of 6 to 10 mm and multiple stents 
of 7 Fr to 10 Fr repeated for 12 to 24 months.
42,59,68 An increas-
ing number of stents can be used at each session to achieve a 
maximum diameter. The treatment is usually completed in 1 
year with an average of 3 to 4 stent exchange sessions.
18,21,59,66,69 
Figs 2 and 3 illustrate the cholangiographic appearances of AS 
before and after endoscopic treatment in living and DDLT.
The overall long-term success rate of endoscopic treat-
ment for AS associated with DDLT is in the range of 70% to 
100%.
18,20,21,57,59,66,69-71 However, endoscopic treatment success 
rates in AS after LDLT appears significantly less than AS for 
DDLT at 37% to 71% (Tables 1 and 2).
62,72,73 When AS are treat-
ed appropriately, the long-term results in terms of patient and 
graft survival are equivalent to those for matched controls with-
out AS.
18,57,66,74 A protocol of accelerated dilation every 2 week, 
and a shortened stenting period of an average of 3.6 months, 
showed some encouraging results with a high 87% success 
rate.
68
In patients with duct to duct anastomosis, endoscopic man-
agement is hence first line, and it appears that while repeat 
endoscopic treatment is needed, shorter intervals in between 
treatments may ultimately reduce the time needed for success-
ful long term outcomes. Despite of limited data, there is some 
experience in temporary placement of covered self-expanding 
metal stents to reduce the need for repeated stent exchanges 
but long term results not identified. In the few situations when 
endoscopic access to the AS is not obtainable, as in Roux-en-Y 
reconstructions, another option could be considered. A com-
Table 1. Results of Endoscopic Therapy of Post-Transplant Biliary Anastomotic Stricture in Transplants from a Deceased Donor: A Review of the 
Literature
Author Patients
Interval 
LTx first 
ERC, mo
No. of 
interventions
Success rate of 
endoscopic 
treatment, %
Treatment 
modality
Duration of  
therapy, mo
Stent-free 
follow-up, mo
Anastomotic 
stricture 
recurrence 
rate, %
Complications, 
%
Rerknimitr et al. 
(2002)
18 43
8.3
(0.5-60)
3.8
(1-8)
100 BD+stent
15.8
(1.5-40)
39 (median) 0 6.6
Thuluvath et al. 
(2003)
69 19 -
3.5
(1-16)
74 BD+stent 3-6 34 (mean) - 12
Zoepf et al. 
(2006)
65 25
5
(1-33)
4
(1-11)
88 BD+stent
3.5
(1-24)
4 (median) 31 24
Holt et al. 
(2007)
87 53 -
3
(2-4)
69 BD+stent
11.3
(7-14)
18 (median) 3 20.7
Pasha et al. 
(2007)
88 25
2
(0.2-24)
3.5
(1-9)
88 BD+stent
4.6
(1.1-11.9)
21.5 (median) 18 5
LTx, liver transplantation; ERC, endoscopic retrograde cholangiography; BD, balloon dilatation.
Table 2. Results of Endoscopic Therapy of Post-Transplant Biliary Anastomic Stricture in Transplants from a Living Donor: A Review of the Lit-
erature
Author Patients
Interval 
LTx first 
ERC, mo
No. of 
interventions
Success rate of 
endoscopic 
treatment, %
Treatment 
modality
Duration of 
therapy, mo
Stent-free 
follow-up, mo
Anastomotic 
stricture 
recurrence 
rate, %
Complications, 
%
Tsujino et al. 
(2006)
62   17
5.9
(1.3-12.2)
4.1
(2-8)
71 BD±stent - - - -
Kim et al. 
(2009)
72   60 -
2
(1-6)
63 BD+stent -   7.9 (1.0-27.3) 13 32
Kato et al. 
(2009)
89   41
2.8
(0.7-14)
4
(1-11)
51 BD±stent
16.6
(0.7-39.6)
-- 1 9
Seo et al. 
(2009)
90   68 8.6
2.3
(1.6-3.0)
64.5 BD+stent
6.8
(3.9-9.7)
  12 (median) 30 20.2
Chang et al. 
(2010)
17 113
6
(1-71)
3.2
(1-11)
26.5 BD+stent -   22 (median) -
10.6
(immediate)
29.2 (late)
Kim et al. 
(2011)
73 147 5.6
6.3
(2.9-9.7)
36.9 BD±stent
12.7
(3.2-22.2)
 21.1 (mean) 11.5   7.2
LTx, liver transplantation; ERC, endoscopic retrograde cholangiography; BD, balloon dilatation.138  Gut and Liver, Vol. 5, No. 2, June 2011
bined approach where access to the biliary tree is obtained via 
a percutaneous transhepatic route followed by “rendezvous” 
endoscopy.
54,75 The use of percutaneous transhepatic drainage 
achieves success rates of 50% to 75%.
76-79 Surgical revision and 
biliary reconstruction with the formation of a hepaticojejunos-
tomy is indicated when endoscopic or percutaneous treatment 
fails.
ENDOSCOPY PROTOCOL
Endoscopic interventions were performed with duodenoscope 
after overnight fasting. After selective bile duct cannulation, 
anastomotic stricture could be detected as a dominant narrow-
ing at the anastomotic site, without effective passage of contrast 
material, as identified by cholangiography. If the guidewire 
(0.025 or 0.035 inch) pass into the intrahepatic duct proximal 
to the site of the stricture, endoscopic sphincterotomy or endo-
scopic papillary balloon dilation was performed to allow place-
ment of stent. 
The anastomotic stricture was then dilated by using high 
pressure pneumatic balloons that ranged in size from 4 to 
10 mm for 30 to 60 seconds. The Soehendra biliary dilation 
catheter or Soehendra stent retriever (Wilson-Cook Medical GI 
Endoscopy, Winston-Salem, NC, USA) was sometimes used to 
dilate the stricture site. A 7 to 10 Fr straight or pigtail plastic 
stent was inserted after balloon dilatation (Fig. 4).
According to the characteristics of the stricture, including its 
location, severity of tightness, and angulation, we decided the 
number, size and form of the stents. For example, if an angula-
tion was present near the stricture site and straightening and 
migration of the stent was anticipated, a double pig-tail stent 
was regarded as adequate. If the guidewire could not be passed 
through the stricture site or minimal narrowing at the anasto-
mosis site that did not impede the flow of contrast material, the 
percutaneous transhepatic approach was used after the nasobili-
ary tube was placed distal to the stricture site.
After the initial endoscopic session, ERCP was scheduled 
electively at intervals of 2 to 3 months for evaluation of the 
Fig. 4. Instruments used for biliary dilatation and stenting. (A) Controlled Radial Expansion (CRE) wire-guided balloon dilatation catheter (Boston 
Scientific Microvasive). (B) The tips of the Soehendra® biliary dilatation catheter and (C) a Soehendra® stent retriever. (D) From left to right, a dou-
ble pig-tail stent (Solus double pigtail stent), a single pig-tail stent (Zimmon® pancreatic stent) and a straight plastic (Cotton-Leung® Amsterdam 
style biliary stent) stent (all produced by Wilson-Cook Medical GI endoscopy).Ryu CH, et al: Biliary Strictures after Liver Transplantation  139
stricture and for stent change. ERCP was performed earlier in 
cases of cholangitis or worsening liver function. At follow-up 
ERCP, the stents were removed by using the polypectomy snare 
or rat tooth forceps. A cholangiogram by occluding the distal 
common bile duct with a distended retrieval balloon (8.5 to 15 
mm) showed a patent anastomotic stricture, then treatment dis-
continued. If not, balloon dilatation and stent placement were 
repeated at intervals of 2 to 3 months until the stricture were re-
solved. Fig. 5 summarized the schematic diagram of therapeutic 
approach for post-LDLT with duct to duct biliary stricture.
73
FUTURE DIRECTIONS
Use of new intraductal endoscopy technologies such as the 
SpyGlass direct visualization system (Boston Scientific, Natick, 
MA, USA), which allows visualization of the inner wall of the 
biliary tree and can act as the guidance system for passage of 
the guidewire through a tight stricture, has shown some early 
promise in this area.
61,80-82
New types of balloons and stents will have significant role in 
improvement of management of biliary stricture. Preliminary 
evidence shows that peripheral cutting balloons may be more 
effective in benign biliary stricture not responsive to standard 
measures.
83 Metal stents have been employed in an effort to re-
duce stricture recurrence and maintain duct patency. Traditional 
open-mesh metal stents are associated with occlusion, stone for-
mation, and lack of permanency, epithelial hyperplasia.
84 These 
disadvantages of metal stents have traditionally limited their 
use in benign biliary strictures. The drawbacks of uncovered 
metal stents have led to the use of covered metal stents, with 
the potential benefit that these stents can be removed. However, 
the use of covered metal stents needs further evaluation to de-
termine their therapeutic effectiveness. Self-expanding stents 
made of bioabsorbable material may offer several advantages 
compared to the plastic and self-expanding metal stents.
85,86 
Studies in porcine models show that these stents offer improved 
patency because of their large diameter, lower biofilm accumu-
lation and reduced incidence of bile duct proliferative changes. 
Furthermore, patients do not have to undergo additional proce-
dures to remove the stents. Bioabsorbable stents can be impreg-
nated with pharmaceutical compounds, such as antimicrobial 
and antineoplastic agents. However, these stents remains inves-
tigational at the present time. 
CONCLUSIONS
The landscape related to biliary complications after liver 
transplantation has changed rather rapidly in the past 2 de-
cades. The conventional management of these conditions in the 
past was mainly surgical. However, therapeutic endoscopy plays 
an important role in the treatment of post-liver transplant anas-
tomotic strictures. At present, the preferred endoscopic approach 
is repeated aggressive dilation of the stricture and insertion of 
multiple plastic stents, particularly anastomotic stricture. Per-
cutaneous and surgical modalities are now reserved for patients 
in whom endoscopic treatment fails and for those with multiple 
inaccessible intrahepatic strictures or Roux-en-Y anastomoses. 
With advances of small bowel endoscopy, Roux-en-Y anasto-
mosis site is accessible to endoscopic treatments. Fully covered 
metal stents or bioabsorbable stents may provide superior re-
sults and deserve further investigation. The area of therapeutic 
endoscopy will continue to evolve and offer opportunities for 
innovative new techniques in orthotopic liver transplantation 
patient related to biliary stricture. 
Fig. 5. Schematic of the therapeutic 
approach for the treatment of post 
LDLT biliary stricture. 
LDLT, living donor liver transplan-
tation; ERC, endoscopic retrograde 
cholangiography; ENBD, endoscopic 
nasobiliary drainage catheter.  140  Gut and Liver, Vol. 5, No. 2, June 2011
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